There is an urgent need for equitable care and access to cardiovascular care, said Vallerie McLaughlin, MD; Martha Gulati, MD; and Stephen Nicholls, MBBS, PhD.
Stephen Nicholls, MBBS, PhD, MBA
Advertisement
Stephen Nicholls, MBBS, PhD, MBA, is a professor of cardiology at Monash University, the program director of the Victorian Heart Hospital at Monash Health, and the director of the Monash Victorian Heart Institute in Melbourne, Australia.
Articles by Stephen Nicholls, MBBS, PhD, MBA
Tirzepatide's dual mechanism targets GIP and GLP-1, so it provides strong cardiovascular benefits, said Stephen Nicholls, MBBS, PhD, MBA.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
How Hospital Specialty Pharmacies Are Closing the Pharmacy Desert Gap
2
Patients on GLP-1s Increasingly Carry Diagnoses for New Indications
3
Targeting Oxidative Stress Could Fill a Gap in the Vitiligo Treatment Toolbox
4
Special Report: The Oncology Care Model, 10 Years Later
5